Patients after Bariatric Surgery. Other obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Obese men and women (BMI =30) Absence of medically unstable hemodynamic conditions Absence of movement disorders No underlying conditions such as advanced pulmonary/kidney diseases, liver cirrhosis, hepatitis, or gastrointestinal disorders (e.g., celiac disease, diverticulosis) No use of medications, tobacco, alcohol, or supplements Completing the PRQ form for more accurate assessment of physical health in individuals
Exclusion criteria
Exclusion criteria: Individuals allergic to nano-curcumin or other plants of the Zingiberaceae family Second surgery Use of alcohol and medications (metformin, levothyroxine, cortisone, and topiramate) within 1 month prior to the study Unwillingness to continue participation in the study Absence from more than three research sessions or failure to take nano-curcumin capsules more than twice Occurrence of any health risks or complications for patients during the study protocol implementation, as confirmed by the attending physician Age Range:30-45 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Low-density lipoprotein. Timepoint: Measurements will be conducted at baseline (pre-intervention) and 60 days after initiating nano-curcumin supplementation and the selected training protocol. Method of measurement: Measurements will be performed using standard laboratory kits.;High-density lipoprotein. Timepoint: Measurements will be conducted at baseline (pre-intervention) and 60 days after initiating nano-curcumin supplementation and the selected training protocol. Method of measurement: Measurements will be performed using standard laboratory kits.;Ferritin. Timepoint: Measurements will be conducted at baseline (pre-intervention) and 60 days after initiating nano-curcumin supplementation and the selected training protocol. Method of measurement: Measurements will be performed using standard laboratory kits.;Albumin. Timepoint: Measurements will be conducted at baseline (pre-intervention) and 60 days after initiating nano-curcumin supplementation and the selected training protocol. Method of measurement: Measurements will be performed using standard laboratory kits.;Hemoglobin. Timepoint: Measurements will be conducted at baseline (pre-intervention) and 60 days after initiating nano-curcumin supplementation and the selected training protocol. Method of measurement: Measurements will be performed using standard laboratory kits.;Alanine Aminotransferase. Timepoint: Measurements will be conducted at baseline (pre-intervention) and 60 days after initiating nano-curcumin supplementation and the selected training protocol. Method of measurement: Measurements will be performed using standard laboratory kits.;Aspartate Aminotransferase. Timepoint: Measurements will be conducted at baseline (pre-intervention) and 60 days after initiating nano-curcumin supplementation and the selected training protocol. Method of measurement: Measurements will be performed using standard laboratory kits.;Triglyceride. Timepoint: Measurements will be conducted at baseline (pre-intervention) | — |
Secondary
| Measure | Time frame |
|---|---|
| Palatable Food Craving Questionnaire - Trait (PFQ-T). Timepoint: The questionnaire will be administered at baseline (pre-intervention) and 60 days after initiating nano-curcumin supplementation and the selected training protocol. Method of measurement: The PFQ-T questionnaire will be completed by patients before and after the research protocol, with all resulting data collected. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University